학술논문
1325P Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S1015-S1016
Subject
Language
ISSN
0923-7534